UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.22 +0.84 (+1.07%) GOLD FUTURES
2,316.10 -8.10 (-0.35%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,262.96 -1,027.92 (-2.04%)
Aarti Drugs Limited (AARTIDRUGS.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 03:29PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 43.76B |
| Enterprise value | 49.20B |
| Trailing P/E | 25.65 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.73 |
| Price/book (mrq) | 3.41 |
| Enterprise value/revenue | 1.95 |
| Enterprise value/EBITDA | 15.35 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.88 |
| 52-week change 3 | 5.46% |
| S&P500 52-week change 3 | 25.38% |
| 52-week high 3 | 624.00 |
| 52-week low 3 | 429.45 |
| 50-day moving average 3 | 485.39 |
| 200-day moving average 3 | 513.07 |
Share statistics
| Avg vol (3-month) 3 | 16.46k |
| Avg vol (10-day) 3 | 11.76k |
| Shares outstanding 5 | 91.94M |
| Implied shares outstanding 6 | 92.76M |
| Float 8 | 33.34M |
| % held by insiders 1 | 63.07% |
| % held by institutions 1 | 6.47% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1 |
| Forward annual dividend yield 4 | 0.21% |
| Trailing annual dividend rate 3 | 1.00 |
| Trailing annual dividend yield 3 | 0.21% |
| 5-year average dividend yield 4 | 2.33 |
| Payout ratio 4 | 5.39% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 06 Feb 2024 |
| Last split factor 2 | 4:1 |
| Last split date 3 | 30 Sept 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 6.78% |
| Operating margin (ttm) | 11.82% |
Management effectiveness
| Return on assets (ttm) | 6.93% |
| Return on equity (ttm) | 13.87% |
Income statement
| Revenue (ttm) | 25.29B |
| Revenue per share (ttm) | 275.02 |
| Quarterly revenue growth (yoy) | -16.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 3.2B |
| Net income avi to common (ttm) | 1.71B |
| Diluted EPS (ttm) | 18.56 |
| Quarterly earnings growth (yoy) | -15.50% |
Balance sheet
| Total cash (mrq) | 207.7M |
| Total cash per share (mrq) | 2.26 |
| Total debt (mrq) | 5.64B |
| Total debt/equity (mrq) | 44.02% |
| Current ratio (mrq) | 1.66 |
| Book value per share (mrq) | 139.39 |
Cash flow statement
| Operating cash flow (ttm) | 3.59B |
| Levered free cash flow (ttm) | 1.22B |
© 2024 Yahoo. All rights reserved.